Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurofibromin 1 pseudogene 10 (NF1P10) is, based on nomenclature, likely a nonfunctional, noncoding genomic sequence with homology to the neurofibromin 1 (NF1) gene, which encodes a GTPase-activating protein involved in negative regulation of Ras signaling[1][3][5]. Unlike the functional NF1 gene, which is a well-established tumor suppressor associated with neurofibromatosis type 1 and various cell signaling pathways, pseudogenes such as NF1P10 generally do not code for proteins, are not implicated in disease, and are not considered therapeutic targets. There are documented NF1 pseudogenes located on several chromosomes (e.g., chromosomes 2, 14, 22), but "NF1P10" is not recognized among them in major scientific repositories[4][5]. Summary of Issues: - *NF1P10* is most likely either a misnamed or uncharacterized pseudogene. - It is not a drug target, has no biological function, and is not associated with known disease or pharmacology. - There is insufficient or no evidence to classify it among molecular targets, and it should not be considered a receptor, enzyme, or functional biomolecule[4][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurofibromin 1 pseudogene 10 (NF1P10).